HIV - specific T cell responses were detected in 63 %
of vaccinees.
«Influenza vaccines have been in use for over 50 years, but there are very few studies that have been able to follow the same people for a long period of time particularly in such a well documented group
of vaccinees.»
Not exact matches
Day - to - day reactogenicity and the healthy
vaccinee effect
of measles - mumps - rubella vaccination
322 Additional subsequent large population case - control trials consistently have found vaccines to be protective against SIDS323, — , 325; however, confounding factors (social, maternal, birth, and infant medical history) might account for this protective effect.326 It also has been theorized that the decreased SIDS rate immediately after vaccination was attributable to infants being healthier at time
of immunization, or «the healthy
vaccinee effect.»
Results from the RV144 trial, reported in 2009, provided the first signal
of HIV vaccine efficacy: a 31 percent reduction in HIV infection among
vaccinees.
Many RV144
vaccinees produced antibodies in the immunoglobulin G (IgG) family that bind to sites within part
of the HIV envelope called V1V2.